IP Library Granted Patent US 8,386,046
Granted Patent B2
US 8,386,046 · App. 13/251,856 · Granted Feb 26, 2013

Screening devices and methods for obstructive sleep apnea therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,386,046
App. No.
13/251,856
Granted
Feb 26, 2013
Kind
B2
Abstract

Devices and methods for treating obstructive sleep apnea by first performing an assessment of the patient that involves observing the patient's upper airway during a tongue protrusion maneuver. The assessment may, for example, be done using endoscopy to observe the upper airway while the patient is awake in the supine position. An adequate response of the upper airway during the tongue protrusion maneuver is indicative of likely therapeutic success with hypoglossal nerve stimulation, and may be used for making clinical decisions. The principles of the present invention may be applied to other therapeutic interventions for OSA involving the upper airway.

Claims (27)

1. A method of providing therapy to a patient, comprising:

performing an assessment of the patient, wherein the assessment comprises protruding the patient's tongue without electrical stimulation of a nerve of the patient, wherein the tongue protrusion is volitional, and observing a response of the patient's upper airway; and

implanting a hypoglossal nerve stimulation device in the patient only if the response comprises an increase in airway size.

2. A method as in claim 1 , wherein the upper airway is observed while the patient is awake and supine.

3. A method as in claim 1 , wherein the upper airway is observed by endoscopy.

4. A method as in claim 3 , wherein the increase in airway size is at least one of retro-glossal and retro-palatal.

5. A method as in claim 3 , wherein the increase in airway size comprises increase in one of an anterior-posterior dimension and a lateral dimension.

6. A method as in claim 1 , wherein the assessment further comprises determining a level of collapse in the patient's upper airway.

7. A method as in claim 1 , wherein the patient is treated with the therapy only if the response of the upper airway is an increase in size, and only if another response is observed during tongue protrusion.

8. A method of providing therapy to a patient, comprising:

performing a tongue protrusion maneuver without electrical stimulation of a nerve of the patient, wherein the tongue protrusion is volitional, and observing a response of the patient's upper airway; and

treating the patient's upper airway with a therapy as a function of the observed response.

9. A method as in claim 8 , wherein the therapy comprises a treatment for obstructive sleep apnea.

10. A method as in claim 9 , wherein the therapy comprises a surgical procedure modifying tissue of the upper airway.

11. A method as in claim 9 , wherein the therapy comprises implanting a device in the upper airway.

12. A method as in claim 9 , wherein the upper airway is observed while the patient is awake and supine.

13. A method as in claim 12 , wherein the upper airway is observed by endoscopy.

14. A method as in claim 13 , wherein the increase in airway size is at least one of retro-glossal and retro-palatal.

15. A method as in claim 13 , wherein the increase in airway size comprises an increase in one of an anterior-posterior dimension and a lateral dimension.

16. A method as in claim 8 , wherein the assessment further comprises determining the level of collapse in the patient's upper airway.

17. A method of providing therapy to a patient, comprising:

performing a palatoglossal arch maneuver and observing a response of the patient's upper airway, wherein the palatoglossal arch maneuver includes volitional tongue protrusion in the absence of electrical stimulation; and

treating the patient's upper airway with a therapy as a function of the observed response.

18. A method as in claim 17 , wherein the upper airway is observed while the patient is awake and supine.

19. A method as in claim 18 , wherein the upper airway is observed by endoscopy.

20. A method as in claim 19 , wherein the increase in airway size is at least one of retro-glossal and retro-palatal.

21. A method as in claim 19 , wherein the increase in airway size comprises an increase in one of an anterior-posterior dimension and a lateral.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2014
From: APNEX MEDICAL, INC.
To: CYBERONICS, INC.
Reel/Frame 032244/0509 →
SECURITY AGREEMENT Recorded Oct 17, 2012
From: APNEX MEDICAL, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP
Reel/Frame 029141/0956 →